Plasmodium falciparum Isolates in India Exhibit a Progressive Increase in Mutations Associated with Sulfadoxine-Pyrimethamine Resistance

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 3, 2004, Pages 879-889

  Ahmed, Anwar ^a   Bararia, Deepak ^a   Vinayak, Sumiti ^a   Yameen, Mohammed ^a   Biswas, Sukla ^b   Dev, Vas ^b   Kumar, Ashwani ^b   Ansari, Musharraf A ^b   Sharma, Yagya D ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR;

ARTICLE; DRUG RESISTANCE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; INDIA; MUTATION RATE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ALLELES; ANIMALS; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; FOLIC ACID ANTAGONISTS; GENOTYPE; HUMANS; INDIA; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 1442300135     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.3.879-889.2004     Document Type: Article

References (42)

1. Basco, L. K. 2002. Molecular epidemiology of malaria in Cameroon XII, in vitro drug assays and molecular surveillance of chloroquine and proguanil resistance. Am. J. Trop. Med. Hyg. 67:383-387.
2. Basco, L. K., P. E. De Pecoulas, C. M. Wilson, J. LeBras, and A. Mazabraud. 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 69:135-138.
3. Biswas, S. 2001. Plasmodiumfalciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study. Ind. J. Malariol. 38:76-83.
4. Biswas, S., A. Escalante, S. Chaiyaroj, P. Angkasekwinai, and A. A Lal. 2000. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Indian and Thailand: a molecular epidemiologic study. Trop. Med. Int. Health 5:737-743.
5. Brooks, D. R., P. Wang, M. Read, W. M. Watkins, P. F. Sims, and J. E. Hyde. 1994. Sequence variation of the hydroxymethyl dihydropterin pyrophosphokinase:dihydropteroate synthetase gene in lines of the human malaria parasite Plasmodium falciparum with differing resistance to sulfadoxine. Eur. J. Biochem. 224:397-405.
6. Bwijo, B., A. Kaneko, M. Takechi, I. L. Zungu, Y. Moriyama, J. K. Lum, T. Tsukahara, T. Mita, N. Takahashi, Y. Bergqvist, A. Bjorkman, and T. Kobayakawa. 2003. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop. 85:363-373.
7. Checchi, G., R. Durand, S. Balkan, B. T. Vonhm, J. Z. Kollie, P. Biberson, E. Baron, J. LeBras, and J.-P. Guthmann. 2002. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Happer, Liberia: results in vivo and analysis of point mutations. Trans. R. Soc. Trop. Med. Hyg. 96:664-669.
8. Contreras, C., J. F. Cortese, A. Caraballo, and C. V. Plowe. 2002. Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar. Am. J. Trop. Med. Hyg. 67:400-405.
9. Eldin de Pecoulas, P., L. K. Basco, B. Abdullah, M. K. Dje, J. LeBras, and A. Mazabraud. 1995. Plasmodium falciparum: detection of antifolate resistance by mutation specific restriction enzyme digestion. Exp. Parasitol. 80: 483-487.
10. Foley, M., L. C. Ranford-Cartwright, and H. A. Babiker. 1992. Rapid and simple method for isolating malaria DNA from fingerprick samples of blood. Mol. Biochem. Parasitol. 53:241-244.
11. Foote, S. J., D. Galatis, and A. F. Cowman. 1990. Amino acids in the dihydrofolate reductase thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. USA 87:3014-3017.
12. Gyang, F. N., D. S. Peterson, and T. E. Wellems. 1992. Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine. Exp. Parasitol. 74:470-472.
13. Jafari, S., J. LeBras, M. Asmar, and R. Durand. 2003. Molecular survey of Plasmodium falciparum resistance in south-eastern Iran. Ann. Trop. Med. Parasitol. 97:119-124.
14. Khalil, I., M. Alifrangis, A. M. Ronn, H. A. Gabar, T. Jelinek, G. M. H. Satti, and I. B. C. Bygbjerg. 2002. Pyrimthamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels and treatment outcome. Am. J. Trop. Med. Hyg. 67:225-229.
15. Khan, B., S. Omar, J. N. Kanayara, M. Warren-Perry, J. Nyalwidhe, D. S. Peterson, T. Wellems, S. Kaniaru, J. Gitonga, F. J. Mulaa, and D. K. Koech. 1997. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya. Trans. R. Soc. Trop. Med. Hyg. 91:456-460.
16. Kublin, J. G., F. K. Dzinjalamala, D. D. Kamwendo, E. M. Malkin, J. F. Cortese, L. M. Martino, R. A. G. Mukadam S. J. Rogerson A. G. Lescano, M. E. Molyneux, P. A. Winstanley, P. Chimpeni, T. E. Taylor, and C. V. Plowe. 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185:380-388.
17. Kublin, J. G., R. S. Witzig, A. H. Shanker, J. Q. Zurita, R. H. Gilman, J. A. Guarda, J. F. Cortese, and C. V. Plow. 1998. Molecular assays for surveillance of antifolate resistant malaria. Lancet 351:1629-1630.
18. Le Bras, J., and R. Durand. 2003. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam. Clin. Pharmacol. 17:147-153.
19. Mawili-Mboumba, D. P., M. T. Ekala, F. Lekoulou, and F. Ntoumi. 2001. Molecular analysis of DHFR and DHPS genes of P. falciparum clinical isolates from the Haut-Ogooue region in Gabon. Acta Trop. 78:231-240.
20. Mberu, E. K., M. K. Mosobo, A. M. Nzila, G. O. Kokwaro, C. H. Sibley, and W. M. Watkins. 2000. The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. Am. J. Trop. Med. Hyg. 52:396-401.
21. Mberu, E. K., A. M. Nzila, E. Nduati, A. Ross, S. M. Monks, G. O. Kokwaro, W. M. Watkins, and C. H. Sibley. 2002. Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinant in sulfa resistance. Exp. Parasitol. 101:90-96.
22. Misra, S. P. 1996. In-vivo resistance to chloroquine and sulfadoxine/pyrimethamine combination in Plasmodium falciparum in India. Proc. Natl. Acad. Sci. India 66:123-138.
23. Nagesha, H. S., D. Syafruddin, G. J. Casey, A. I. Susanti, D. J. Fryauff, J. C. Reeder, and A. F. Cowman. 2001. Mutations in the pfmdrl, dhfr and dhps genes of Plasmodium falciparum are associated with in vivo drug resistance in West Papua, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 95:43-49.
24. Ngo, T., M. Duraisingh, M. Reed, D. Hipgrave, B. Biggs, and A. F. Cowman. 2003. Analysis of Pfcrt, Pfmdr1, DHFR and DHPS mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. Am. J. Trop. Med. Hyg. 68: 350-356.
25. Pearce, R. J., C. Drakeley, D. Chandramohan, F. Mosha, and C. Roper. 2003. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthetase of Plasmodium falciparum in these districts of northern Tanzania. Antimicrob. Agents Chemother. 47: 1347-1354.
26. Peterson, D. S., W. K. Milhous, and T. E. Wellems. 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 87:3018-3022.
27. Plowe, C. V., J. F. Cortese, A. Djimde, O. C. Nwanyanwu, W. M. Watkins, P. A. Winstanley, J. G. Estrada-Franco, R. E. Mollinedo, J. C. Avila, J. L. Cespeds, D. Carter, and O. K. Doumbo. 1997. Mutation in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176:1590-1596.
28. Plowe, C. V., A. Djimde, M. Bouare, O. Doumbo, and T. E. Wellems. 1995. Pyrimethamine proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction method for surveillance in Africa. Am. J. Trop. Med. Hyg. 52:565-568.
29. Reeder, J. C., K. H. Rieckmann, B. Genton, K. Lorry, B. Wines, and A. F. Cowman. 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am. J. Trop. Med. Hyg. 55:209-213.
30. Roper, C., R. Pearce, B. Bredenkamp, J. Gumede, C. Drakeley, F. Mosha, D. Chandramohan, and B. Sharp. 2003. Antifolate antimalarial resistance in southeast Africa: a population based analysis. Lancet 361:1174-1181.
31. Sharma, V. P. 1999. Current scenario of malaria in India. Parasitologia 41: 349-353.
32. Sharma, Y. D., S. Biswas, C. R. Pillai, M. A. Ansari, T. Adak, and C. Ushadevi. 1996. High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic. Acta Trop. 62:135-141.
33. Singh, J. C., R. Zakaria, M. S. Abdullah, H. A. Rahman, S. Nagappan, and B. Singh. 2001. Differences in dihydrofolate reductase but not dihydropteroate synthase alleles in Plasmodium falciparum isolates from geographically distinct areas in Malaysia. Am. J. Trop. Med. Hyg. 64:28-31.
34. Sirawaraporn, W., T. Sathitkul, R. Sirawaraporn, Y. Yuthavong, and D. V. Santi. 1997. Antifolate-resistance mutants of Plasmodium falciparum dihydrofolate reductase. Proc. Natl. Acad. Sci. USA 94:1124-1129.
35. Triglia, T., and A. F. Cowman. 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 91:7149-7153.
36. Triglia, T., J. G. T. Menting, C. Wilson, and A. F. Cowman. 1997. Mutations in dihydropteroate synthetase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 94:13944-13949.
37. Vinayak, S., S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma. 2003. Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. Acta Trop. 87:287-293.
38. Wang, P., D. R. Brooks, P. F. G. Sims, and J. E. Hyde. 1995. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol. Biochem. Parasitol. 71:115-125.
39. Wang, P., C.-S. Lee, R. Bayoumi, A. Djimde, O. Doumbo, G. Swedberg, L. D. Das, H. Mshinda, M. Tanner, W. M. Watkins, P. F. G. Sims, and J. E. Hyde. 1997. Resistance to antifolate in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a larger number of field samples of diverse origin. Mol. Biochem. Parasitol. 89:161-177.
40. Watkins, W. M., and M. Mosobo. 1993. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans. R. Soc. Trop. Med. Hyg. 87: 75-78.
41. Yuvaniyama, J., P. Chitnumsub, S. Kamchonwongpaisan, J. Vanichtanankul, W. Sirawaraporn, P. Taylor, M. D. Walkinshaw, and Y. Yuthavong. 2003. Insights into antifolate resistance from malarial DHFR-TS structures. Nat. Struct. Biol. 10:357-365.
42. Zindrou, S., N. P. Dung, N. D. Sy, O. Skold, and G. Swedberg. 1996. Plasmodium falciparum: mutation pattern in the dihydrofolate reductase thymidylate synthase genes of Vietnamese isolates, a novel mutation, and co-existence of two clones in a Thai patient. Exp. Parasitol. 84:56-64.